Pembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma

Name: Pembrolizumab With Rituximab or Obinutuzumab in Treating Patients With Relapsed or Refractory Follicular Lymphoma or Diffuse Large B Cell Lymphoma
License: Public Domain

University of Washington

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

recurrent diffuse large b-cell lymphoma, recurrent follicular lymphoma, refractory diffuse large b-cell lymphoma, refractory follicular lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 300266
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.